Primary Peptides

Primary Peptides is a clinical-stage company focused on the fields of cardiovascular diseases, oncology, and neurodegenerative diseases. Primary Peptides was established to leverage its founders' and collaborators' extensive knowledge of neuroscience and proteomics. Primary Peptides has identified a series of key domains in disease-related proteins and designed peptides to block the interactions of these disease-related proteins, thereby providing new therapeutic approaches to either target or reduce the levels of specific disease-related proteins in the body.